| Literature DB >> 33219330 |
Alexandre Bodin1,2, Valérie Labas3,4, Arnaud Bisson5, Ana-Paula Teixeira-Gomes6, Hélène Blasco7, Daniel Tomas3,4, Lucie Combes-Soia3,4, Paulo Marcelo8, Elodie Miquelestorena-Standley9, Christophe Baron9, Denis Angoulvant5,9, Dominique Babuty5, Nicolas Clementy5,9.
Abstract
Implantable cardioverter-defibrillators (ICD) are meant to fight life-threatening ventricular arrhythmias and reduce overall mortality. Ironically, life-saving shocks themselves have been shown to be independently associated with an increased mortality. We sought to identify myocardial changes at the protein level immediately after ICD electrical shocks using a proteomic approach. ICD were surgically implanted in 10 individuals of a healthy male sheep model: a control group (N = 5) without any shock delivery and a shock group (N = 5) with the delivery of 5 consecutive shocks at 41 J. Myocardial tissue samples were collected at the right-ventricle apex near to the lead coil and at the right ventricle basal free wall region. Global quantitative proteomics experiments on myocardial tissue samples were performed using mass spectrometry techniques. Proteome was significantly modified after electrical shock and several mechanisms were associated: protein, DNA and membrane damages due to extreme physical conditions induced by ICD-shock but also due to regulated cell death; metabolic remodeling; oxidative stress; calcium dysregulation; inflammation and fibrosis. These proteome modifications were seen in myocardium both "near" and "far" from electrical shock region. N-term acetylated troponin C was an interesting tissular biomarker, significantly decreased after electrical shock in the "far" region (AUC: 0.93). Our data support an acute shock-induced myocardial tissue injury which might be involved in acute paradoxical deleterious effects such as heart failure and ventricular arrhythmias.Entities:
Mesh:
Year: 2020 PMID: 33219330 PMCID: PMC7679418 DOI: 10.1038/s41598-020-77346-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experimental design. Five sheep in the “control group”: a defibrillation ventricular lead was placed at the right-ventricular apex and connected to a subcutaneous implantable cardiac defibrillator (ICD). No therapy was delivered nor any arrhythmia induced. Five sheep in the “electrical shock group”: ICD implantation was similar. 5 consecutive biphasic maximal energy shocks (41 J) were delivered without arrhythmia. Tissue samples were collected within 10 min at RV apex (“near”) and basal free wall (“far”). A MALDI-TOF MS tissue profiling coupled to a top-down high-resolution mass spectrometry was then performed in order to quantify and identify the intact proteins but also their post-translationnal modifications (PTM). A bottom-up analysis was also carried out, after enzymatic protein digestion, to identify and quantify proteins more exhaustively.
Figure 2MALDI profiling dataset. Representative MALDI spectrum of a myocardial section in the “near” lead region after electrical shocks (A). Venn diagram with four main conditions (B). PCA analysis in “near” region (C) and in “far” region (D), electrical shock group (red dots) can be discriminate from control group (green dots). PC principal components, a.u arbitrary unit. Images included have been created using ClinProTools 3.0 software (Bruker Daltonics, Bremen, Germany, https://www.bruker.com/service/support-upgrades/software-downloads/mass-spectrometry.html).
Occurrence of amino acid residues involved in protein cleavages generating N-terminal, C-terminal or internal fragments.
| Previous residues | Terminal residues | |
|---|---|---|
| N-terminal fragment | – | ADGLR |
| Internal fragment | DFGLR | ADFLR |
| C-terminal fragment | ADFLS | – |
The top five most frequent residues found at the end and above the 62 peptide fragments generated from original proteins are presented.
MALDI-TOF tissular differential peaks identified by Top-down HR-MS.
| MALDI-TOF differential peaks | Top-down HR-MS identification | |||||||
|---|---|---|---|---|---|---|---|---|
| MALDI-TOF peak (m/z) | Fold change (electrical shock/control) | AUC | Gene name | Protein name | BLAST ( | E Value | C Score | |
| 2770.86 | < 0.000001 | 0.75 | 0.67 | ALB | Serum albumin | Internal fragment, 24 amino-acids (aa) | 4.7E-27 | 3.0 |
| 5105.57 | 0.00185 | 1.15 | 0.64 | HSPB1 | - | C-term fragment (56 aa), 100% identity: 27 kDa heat shock protein 1 | 9.06E-8 | 527.3 |
| 5443.32 | 0.00000232 | 1.22 | 0.7 | - | - | C-term fragment (47 aa), 100% identity: cytochrome c oxidase subunit 7C. mitochondrial | 1.97E-23 | 888.4 |
| 6219.54 | < 0.000001 | 1.3 | 0.72 | COX5A | Cytochrome c oxidase subunit 5A | Internal fragment (54 aa) | 4.63E-42 | 609.8 |
| 6946.23 | 0.0026 | 1.16 | 0.62 | HSP90AB1 | - | N-term fragment (60 aa), 100% identity: heat shock protein HSP 90-beta | 1.12E-41 | 1315.0 |
| 8188.31 | 0.00251 | 1.19 | 0.63 | - | - | N-term fragment, 90.3% identity (56/62 aa): 26S proteasome complex subunit SEM1 | 2.55E-20 | 8.7 |
| 8491.39 | < 0.000001 | 1.24 | 0.76 | UBC | Ubiquitin C | N-term fragment (74 aa) with N-acetyl- | 3.44E-43 | 115.9 |
| 8568.22 | < 0.000001 | 1.16 | 0.74 | UBA52 | Ubiquitin-60S ribosomal protein L40 | N-term fragment (76 aa) | 1.52E-62 | 150.2 |
| 10,847.84 | 0.00000675 | 1.15 | 0.69 | HSP10 | HSP10 | Whole protein (101 aa) with | 2.51E-18 | 167.6 |
| 16,925.88 | < 0.000001 | 1.38 | 0.75 | MB | Myoglobin | Whole protein (161 aa) with | 1.04E-9 | 47.6 |
| 2,771.39 | 0.00000262 | 1.24 | 0.69 | ALB | Serum albumin | Internal fragment, 24 amino-acids (aa) | 4.76E-27 | 3.0 |
| 5,105.58 | < 0.000001 | 1.33 | 0.8 | HSPB1 | C-term fragment (56 aa), 100% identity: 27 kDa heat shock protein 1 | 9.06E-8 | 527.3 | |
| < 0.000001 | ||||||||
| 6,219.27 | < 0.000001 | 1.26 | 0.77 | COX5A | Cytochrome c oxidase subunit 5A | Internal fragment (54 aa) | 4.63E-42 | 609.8 |
| < 0.000001 | ||||||||
| 8,188.79 | 0.00000208 | 1.32 | 0.7 | - | N-term fragment, 90.3% identity (56/62 aa): 26S proteasome complex subunit SEM1 | 2.55E-20 | 8.7 | |
| 8,491.39 | < 0.000001 | 1.25 | 0.89 | UBC | Ubiquitin C | N-term fragment (74 aa) with | 3.44E-43 | 115.9 |
| 8,565.03 | < 0.000001 | 1.14 | 0.75 | UBA52 | Ubiquitin-60S ribosomal protein L40 | N-term fragment (76 aa) | 1.52E-62 | 150.2 |
| 10,849.29 | < 0.000001 | 0.82 | 0.8 | HSP10 | HSP10 | Whole protein (101 aa) with | 2.51E-18 | 167.6 |
| < 0.000001 | ||||||||
In bold, 3 significantly differential m/z between electrical shocks and control groups in the MALDI-TOF phenotyping analysis (p value < 0.01, FC > 1.5, AUC > 0.8). Uncharacterized proteins were mapped to the corresponding Ovis aries orthologues by identifying the reciprocal-best-BLAST hits using blastp program (https://blast.ncbi.nlm.nih.gov/Blast.cgi). AUC area under the curve, aa amino-acids.
Figure 3Bottom-up quantitative proteomic dataset of all proteins. (A) Venn diagram with shared and specific identified proteins according to each conditions. (B) Heat map of all identified proteins in two groups with the bottom-up analysis. Green: high abundance, yellow/red: low abundance, white: very low abundance and absence. Images included have been created using Scaffold software (v 4.8.9, Proteome Software, Portland, USA, https://www.proteomesoftware.com/products/scaffold/).
Figure 4Bottom-up quantitative proteomic dataset of differential proteins in each region. (A) Principal components analyses of protein abundances in control and electrical shocks groups across the “near” region. (B) Volcano plot, providing a visual representation of differential protein regulation between electrical shocks and control groups in the “near” region. Green dots represent significantly regulated (p < 0.05) proteins identified between the two groups. (C) PCA across the “far” region. (D) Volcano plot in the “far” region. PC principal components. Images included have been created using Scaffold software (v 4.8.9, Proteome Software, Portland, USA, https://www.proteomesoftware.com/products/scaffold/).